168 related articles for article (PubMed ID: 23213181)
1. Assessing cancer with a blood draw.
Azvolinsky A
J Natl Cancer Inst; 2012 Dec; 104(23):1774-5. PubMed ID: 23213181
[No Abstract] [Full Text] [Related]
2. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
3. Circulating tumour-derived predictive biomarkers in oncology.
Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
[TBL] [Abstract][Full Text] [Related]
4. International Cancer Conference: targeted therapies boom expected in 3-5 years.
Gethins M
J Natl Cancer Inst; 2011 Oct; 103(20):1491-3. PubMed ID: 21972228
[No Abstract] [Full Text] [Related]
5. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response.
Schwarzenbach H
Expert Rev Mol Diagn; 2015 Feb; 15(2):267-75. PubMed ID: 25382372
[TBL] [Abstract][Full Text] [Related]
6. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
Ianov IuK; Novik AA; Belokhvostov AS
Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
[No Abstract] [Full Text] [Related]
8. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.
Kin C; Kidess E; Poultsides GA; Visser BC; Jeffrey SS
Expert Rev Mol Diagn; 2013 Jul; 13(6):581-99. PubMed ID: 23895128
[TBL] [Abstract][Full Text] [Related]
10. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
[TBL] [Abstract][Full Text] [Related]
11. [Circulating cell-free DNA as biomarker for cancer *header*].
Isomursu A; Kononen J; Kuopio T
Duodecim; 2015; 131(5):424-32. PubMed ID: 26237904
[TBL] [Abstract][Full Text] [Related]
12. [Extracellular DNA in plasma--a potential diagnostic marker in oncology].
Gaziev AI; Shaĭhaev GO; Korenev SV
Vopr Onkol; 2008; 54(5):545-54. PubMed ID: 19069466
[No Abstract] [Full Text] [Related]
13. Colorectal cancer stem cells as biomarkers: where it all starts?
Avital I; Summers TA; Steele SR; Waldman S; Nissan A; Bilchik AJ; Protic M; Man YG; Brücher BL; Stojadinovic A
J Surg Oncol; 2013 Jun; 107(8):791-3. PubMed ID: 23512573
[No Abstract] [Full Text] [Related]
14. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
15. [DNA methylation defects in sporadic and hereditary colorectal cancer].
Xicola RM; Llor X
Gastroenterol Hepatol; 2012; 35(7):480-7. PubMed ID: 22459641
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
Frattini M; Balestra D; Verderio P; Gallino G; Leo E; Sozzi G; Pierotti MA; Daidone MG
J Clin Oncol; 2005 May; 23(13):3163-4; author reply 3164-5. PubMed ID: 15860889
[No Abstract] [Full Text] [Related]
17. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
Scolyer RA; Thompson JF
J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
[No Abstract] [Full Text] [Related]
18. Advances in biomarkers for targeted agents.
Maitland ML
Clin Adv Hematol Oncol; 2011 Sep; 9(9):688-90. PubMed ID: 22402514
[No Abstract] [Full Text] [Related]
19. [Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks].
Hinoda Y
Rinsho Byori; 2012 Oct; 60(10):967-8. PubMed ID: 23323461
[TBL] [Abstract][Full Text] [Related]
20. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
Merlio JP
Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
